What is the size of the Primary Cells market in 2023?

The Primary Cells market size is USD 1.8 billion in 2023.

What is the projected CAGR at which the Primary Cells market is expected to grow at?

The Primary Cells market is expected to grow at a CAGR of 10.1% (2024-2033).

List the segments encompassed in this report on the Primary Cells market?

Market.US has segmented the Primary Cells market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Source the market has been segmented into Hematopoietic Cells, Lung Cells, Gastrointestinal Cells, Skin Cells, Liver Cells, Skeletal & Muscle Cells, Renal Cells, Heart Cells, and Others. By Type the market has been segmented into Human Primary Cells and Animal Primary Cells. By Application the market has been segmented into Stem Cell Therapy, Virology, Cancer Research, Tissue Replacement, and 3D Cell Culture. By End-user the market has been segmented into Pharmaceutical & Biotechnology Companies, CROs, and Research Institutes.

List the key industry players of the Primary Cells market?

ZenBio, Thermo Fisher Scientific, STEMCELL Technologies, PromoCell, Merck KGaA, Inventia Life Science, Lonza, Cell Biologics, Inc., Axol Biosciences Ltd., American Type Culture Collection, and AllCells.

Which region is more appealing for vendors employed in the Primary Cells market?

North America is expected to account for the highest revenue share with 35%, and boasting an impressive market value of USD 55.5 Billion. Therefore, the Primary Cells industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Primary Cells?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Primary Cells Market.

Primary Cells Market By Source (Hematopoietic Cells, Lung Cells, Gastrointestinal Cells, Skin Cells, Liver Cells, Skeletal & Muscle Cells, Renal Cells, Heart Cells, and Others), By Type (Human Primary Cells and Animal Primary Cells), By Application (Stem Cell Therapy, Virology, Cancer Research, Tissue Replacement, and 3D Cell Culture), By End-user (Pharmaceutical & Biotechnology Companies, CROs, and Research Institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Oct 2024
Report ID: 125920
Number of Pages: 234
Format:

- ZenBio
- Thermo Fisher Scientific
- STEMCELL Technologies
- PromoCell
- Merck KGaA
- Inventia Life Science
- Lonza
- Cell Biologics, Inc.
- Axol Biosciences Ltd.
- American Type Culture Collection
- AllCells